We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models with reversible gene silencing to accelerate drug development.
We build innovative diagnostic and monitoring tools that empower people to help make better, faster and more complete decisions about their health.
We identify and validate new targets to accelerate pharmaceutical pipelines, unleashing the commercial potential of RNAi to benefit people on a global scale.
We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models with reversible gene silencing to accelerate drug development.
We build innovative diagnostic and monitoring tools that empower people to help make better, faster and more complete decisions about their health.
We identify and validate new targets to accelerate pharmaceutical pipelines, unleashing the commercial potential of RNAi to benefit people on a global scale.
We are driving advancements in human health by providing high-quality animal and cell models for critical in vivo studies. We empower researchers to gain precise control over in vivo gene expression by designing precise, translatable, genetically-engineered animal and cellular models with potent, reversible gene silencing.
Customize RNAi and CRISPR/Cas9 mouse and rat models with potent, reversible gene silencing for drug discovery and target validation.
Learn More
Recreate the architecture and physiology of human organs with clinically relevant 3D tissue cultures developed from induced pluripotent stem cells (iPSCs).
Learn More
Unlock the therapeutic potential of RNA Interference and accelerate the development of new therapies for the world’s most challenging diseases.
Learn MoreWe believe in the power of molecular diagnostics to shed light on crucial information for optimal patient care, leading to the best possible outcome for each individual patient around the world. As an essential partner to patients, physicians, researchers, and pharmaceutical companies navigating the complex landscape of diseases, Mirimus is constantly innovating and evolving its laboratory capabilities to deliver insights from the building blocks of life – DNA, RNA and proteins.
Shed light on the bidirectional link between infections and autoimmunity to optimize health outcomes
Learn More
Deliver on the potential of biosensors in medical diagnostics and disease monitoring by designing cutting-edge biomarkers recognition systems.
Learn MoreOur cutting-edge technology and uniquely skilled scientists have enabled us to decipher new pathways, generate artificial microRNAs which precisely silence genes, and explore the therapeutic potential of aptamers, extracellular vesicles and ADAM10 metalloproteinase in many different fields.
Unlock the therapeutic potential of RNA Interference and accelerate the development of transformative new therapies for the world’s most challenging diseases.
Unlock the therapeutic potential of RNA Interference and accelerate the development of transformative new therapies for the world’s most challenging diseases.
Create smart drug delivery systems by leveraging the cell-targeting abilities, biodistribution profiles, and pharmacokinetics of exosomes, microvesicles, and apoptotic bodies.
Uncover new drug targets which will allow a specific and fine-tuned modulation of ADAM10 proteolytic activity implicated in a wide-range of human disorders.
